PAŘENICA, Jiří, Jiří JARKOVSKÝ, Jan MALÁSKA, Alexandre MEBAZAA, Jana GOTTWALDOVÁ, Kateřina HELÁNOVÁ, Jiří LITZMAN, Milan DASTYCH, Josef TOMANDL, Jindřich ŠPINAR, Ludmila DOSTÁLOVÁ, Petr LOKAJ, Marie TOMANDLOVÁ, Monika PÁVKOVÁ GOLDBERGOVÁ, Pavel ŠEVČÍK and Matthieu LEGRAND. Infectious complications and immune/inflammatory response in cardiogenic shock patients: A prospective observational study. Shock. Philadelphia: Lippincott Williams & Wilkins, vol. 47, No 2, p. 165-174. ISSN 1073-2322. doi:10.1097/SHK.0000000000000756. 2017.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Infectious complications and immune/inflammatory response in cardiogenic shock patients: A prospective observational study
Authors PAŘENICA, Jiří (203 Czech Republic, guarantor, belonging to the institution), Jiří JARKOVSKÝ (203 Czech Republic, belonging to the institution), Jan MALÁSKA (203 Czech Republic, belonging to the institution), Alexandre MEBAZAA (250 France), Jana GOTTWALDOVÁ (203 Czech Republic, belonging to the institution), Kateřina HELÁNOVÁ (203 Czech Republic), Jiří LITZMAN (203 Czech Republic, belonging to the institution), Milan DASTYCH (203 Czech Republic, belonging to the institution), Josef TOMANDL (203 Czech Republic, belonging to the institution), Jindřich ŠPINAR (203 Czech Republic, belonging to the institution), Ludmila DOSTÁLOVÁ (203 Czech Republic, belonging to the institution), Petr LOKAJ (203 Czech Republic, belonging to the institution), Marie TOMANDLOVÁ (203 Czech Republic, belonging to the institution), Monika PÁVKOVÁ GOLDBERGOVÁ (203 Czech Republic, belonging to the institution), Pavel ŠEVČÍK (203 Czech Republic) and Matthieu LEGRAND (250 France).
Edition Shock, Philadelphia, Lippincott Williams & Wilkins, 2017, 1073-2322.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30201 Cardiac and Cardiovascular systems
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 3.005
RIV identification code RIV/00216224:14110/17:00096765
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1097/SHK.0000000000000756
UT WoS 000392813300007
Keywords in English Cardiogenic shock; C-reactive protein; infection; inflammatory response; pentraxin 3; presepsin; procalcitonin
Tags EL OK
Tags International impact, Reviewed
Changed by Changed by: Soňa Böhmová, učo 232884. Changed: 8/3/2018 14:25.
Abstract
Introduction: Patients with cardiogenic shock (CS) are at a high risk of developing infectious complications; however, their early detection is difficult, mainly due to a frequently occurring noninfectious inflammatory response, which accompanies an extensivemyocardial infarction (MI) or a postcardiac arrest syndrome. The goal of our prospective study was to describe infectious complications in CS and the immune/inflammatory response based on a serial measurement of several blood-based inflammatory biomarkers. Methods: Eighty patients with CS were evaluated and their infections were monitored. Inflammatory markers (C-reactive protein, procalcitonin, pentraxin 3, presepsin) were measured seven times per week. The control groups consisted of 11 patients with ST segment elevation myocardial infarction without CS and without infection, and 22 patients in septic shock. Results: Infection was diagnosed in 46.3% of patients with CS; 16 patients developed an infection within 48 h. Respiratory infection was most common, occurring in 33 out of 37 patients. Infection was a significant or even the main reason of death only in 3.8% of all patients with CS, and we did not find statistically significant difference in 3-month mortality between group of patients with CS with and without infection. There was no statistically significant prolongation of the duration of mechanical ventilation associated with infection. Strong inflammatory response is often in patientswith CS due to MI, but we found no significant difference in the course of the inflammatory response expressed by evaluated biomarkers in patients with CS with and without infection. We found a strong relationship between the elevated inflammatory markers (sampled at 12 h) and the 3-month mortality: the area under the curve of receiver operating characteristic ranged between 0.683 and 0.875. Conclusion: The prevalence of infection in patients with CS was 46.3%, and respiratory tract infections were the most common type. Infections did not prolong statistically significantly the duration of mechanical ventilation and did not increase the prevalence of hospital mortality in this high-risk CS population. CS due to acute myocardial infarction was accompanied by a strong and highly variable inflammatory response, but it did not reach the intensity of the inflammatory response observed in patients with septic shock. An extensive immune/inflammatory response in patients with CS is linked to a poor prognosis.
Links
MUNI/A/1362/2015, interní kód MUName: Neurohumorální profil a prognóza pacientů s chronickým srdečním selháním
Investor: Masaryk University, Category A
PrintDisplayed: 16/4/2024 16:28